Trial
NCT00975104
AMG 745 in Subjects With Age-associated Muscle Loss
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Amgen
Collaborators
—
Condition
Age-associated Muscle Loss
Intervention
AMG 745 0.3 mg/kg
Why stopped
Amgen has chosen at this time not to continue with AMG 745 study 20080733
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-10-04